“We need to find a cure for cancer.” It’s a common sentiment among those who have it, had it, lost someone to it or know someone who’s suffered from it. The Susan G. Komen for the Cure has made it their sole mission to help and, in May, released their 2012 research program grants, which take aim at early and late-stage breast disease.
Since 1982, the Komen Foundation has funded $685 million in research grants, 154 grants in 22 states and seven countries.
But what does that mean for patients? We had a chance to talk to Chandini Portteus, the vice president of research, evaluation
and scientific programs at Susan G. Komen for the Cure.
“The important thing to remember about Komen’s research portfolio is that we’ve been funding since 1982, but our portfolio
has shifted over time,” Portteus says. “It has a sense of urgency now. The requirement for the research we fund is to show
impact within a decade for women and men, so we focus on research that reduces the incidence and mortality of breast cancer. We take discoveries from the lab and translate them into the clinic where women participate in the furthering of that knowledge.”
When can we expect to see results from the research you’re funding now? What about the research in previous years — are you seeing results now?
At first, our portfolio was biology-based because in the ‘80s and ‘90s we didn’t know much about the biology of breast
What happens if you fund a study that doesn’t have a positive result or falls completely flat during the research time?
Of course, science fails and every experiment we do isn’t going to turn out to be a cure. The important thing is to understand the lessons learned. Researchers can come to us, especially during our Promise Grants, and tell us they thought they were going to find something, but their path has changed and they want to redirect their research. Or sometimes a drug treatment wasn’t the right one or the drug wasn’t available. We know that science is an art and we have flexibility. We also have an eight-member scientific advisory board that looks at our Promise Grant projects and gives feedback on its direction.
In one study, Hee Lee, Ph.D., at the University of Minnesota is working to develop a prototype cellphone study to deliver information and messaging to empower Korean American women. Why not just create an app, and how has technology changed your studies?
A few years ago, we funded a mammography reminder system on telephones, and the data showed that even women who are insured, college-educated and Caucasian aren’t getting mammograms. Cellphones are a norm for us, and while awareness, education and access are important, we needed to bring cellphones into the study and see how it makes a difference.
What research is lacking?
This is one of the things we talk to our advisers about, and this year, one area we noted that needed more study is that estrogen preceptor positive breast cancer has treatment options, but within five years after diagnosis, they are coming back with a recurrence of their cancer. What is going on there? This year, we focused on the causes.
What about funding drug development?
We don’t fund drug development. Instead, we fund early stage clinical trials for stage 1 or 2. We’re at that translational bridge and we do things that are really moving out of the lab and to the patients. Funding drug development can be cost-prohibitive for us, and we feel our mission is to urge scientists to get from the lab to the bedside where the women can see progress.
It’s been a rough year. How are you looking forward?
We were already set to fund $58 million, and we met our goal. Research is a priority for Komen and always will be. We are mindful that the economy has affected us all, but we’ve been pleased to see how people are still passionate for what we do. Komen will still be there to help you, provide educational resources. We’ll be there at your diagnosis, and to provide support. We were the first advocacy organization. We know women are dying every day, and until no one dies from breast cancer, our work isn’t done.
- Fighting breast cancer
- Former Marine battling breast cancer
- Cancer survivor chooses to stay breast-free
- Lutherans for Liesl
- Beverly woman's fight inspires Making Strides team
- Doctors take a 'risk adapt' approach
- 'I knew what I had to do and that was that'
- Hereditary gene means a greater risk of breast cancer for some
- Annual walk/run honors Danvers native
- Surgeon explains the breast reconstruction process
- Diagnosis a life-changing event for local business owner
- ‘I never thought it could happen to my Mom’
- Survivor sets sights on half-marathon goal
- Breast cancer fight inspires a special hat
- For women in need, local help is available
- Former resident talks about her diagnosis, treatment, and the lingering effects
- Better healing through food
- For local leaders, the ‘power of pink’ prevails
- On a scale of 0 to 4: A guide to understanding the stages of breast cancer
- Constant chemo cravings
- Local News
Outside firm may run school
SALEM -- School leaders are considering handing over a struggling elementary school to a private, nonprofit firm that specializes in turning around low-achieving urban schools. This dramatic step, which would be a first in the city and region, is one
Honoring the end of an era
SALEM -- After Salem Harbor Station closes in May, its huge structures will come down and most of its workers will move on. To make sure their stories don't disappear along with the 500-foot smokestack, 28 students at Montserrat College of Art have b
Suit claims Salem marijuana dispensary too close to park
SALEM -- Two businesses that lost out on provisional licenses to operate marijuana dispensaries are crying foul in a lawsuit filed earlier this week in Suffolk Superior Court. But the operator of the proposed Salem dispensary says he believes the su
Dominick gets a lift
SALEM -- He's got the van. He's got the wheelchair lift. Dominick Pacheco is ready to roll. After a yearslong effort, the disabled 15-year-old boy's family has succeeded in obtaining a van and making it wheelchair-accessible, thus guaranteeing his fu
Embezzler wants to end restitution to nonprofit he put out of business
SALEM -- The former treasurer of the Yellow School Center for the Arts in Byfield is asking a judge to stop making him pay restitution for the more than $100,000 he embezzled from the nonprofit nearly a decade ago. That's because, David Takesian's a
- Peabody firm ordered to pay for unpaid overtime
- Salem man gets two years for drunken driving
- DA: Endicott student claimed ties to Mob after assaults
- Salem woman held after allegedly driving on drugs to store, then home
- Councilors come up with taxi-license compromise
- Lynn woman jailed for stealing handbags
- Suspect in sex abuse dies at hospital
- Beverly loses legal fight over Black Cow
- What's drawing the most visitors?
- North Shore lawmakers support ‘upskirting’ legislation
- Beverly man jailed in torture, death of kitten
- Salem pipeline plan encounters little opposition at hearing
- Danvers plans rally for Olympic medalist
- Salem martial arts instructor remains held
- Heard Around Town: Salem power plant lost a dear friend
- Battle plans laid for green crab
- Trial delayed for Salem mom charged with trying to kill kids
- Man gets 2 to 3 years for attacking girlfriend
- Fate of Brutole's liquor license awaits hearing
- North Shore News in Brief
- Ex-Swampscott cop denied parole in 1987 slaying
- Concern after off-campus incidents lead to arrests in Beverly
- Ash Wednesday observance in Danvers
- Outside firm may run school